While initial screening is highly beneficial, it has its limitations:
- False Positives/Negatives: Sometimes, normal cells may appear abnormal (false positive) or pathological changes might be missed (false negative). - Sampling Errors: If the sample does not include the affected area, the abnormality might be missed. - Interpretation Variability: Different pathologists might interpret the same sample differently, although standard guidelines aim to minimize this.
